Introduction {#s1}
============

The capacity for adult neural repair varies across animals and bears a relationship to the extent of adult neurogenesis in the absence of injury. Adult neural proliferation is absent in *C. elegans* and rare in *Drosophila*, leaving axon repair as a primary mechanism for healing damage to the CNS and PNS. Mammals undergo adult neurogenesis throughout life, but it is limited to particular brain regions and declines with age ([@bib92]). By contrast, select organisms can undergo more extreme neural repair and also typically undergo more extensive ongoing neural differentiation through adulthood. Axolotls and zebrafish are able to repair extensive damage ([@bib92]), while organisms such as planarians and hydra are able to regenerate an entirely new brain through whole-body regeneration ([@bib93]). Based on identification of similar mechanisms of regeneration from the distantly related planarians and acoels, whole body regeneration has been proposed to be an ancestral feature ([@bib22]; [@bib75]). Understanding the regulatory mechanisms of adult neurogenesis could therefore reveal methods to enhance neural repair across species. In particular, specific negative regulators of neurogenesis would be important targets for repair enhancement, but few have yet been identified ([@bib27]).

The planarian *Schmidtea mediterranea* undergoes complete brain regeneration within 1--2 weeks after injury and also perpetual homeostatic replacement of brain tissue, making this species an ideal model to identify such factors. The planarian brain is composed of an anterior bi-lobed cephalic ganglia with axon-rich neuropils containing interneurons and glia, as well as lateral branches with chemosensory, mechanosensory, and other neurons ([@bib1]; [@bib46]; [@bib51]; [@bib77]; [@bib99]). Two ventral nerve cords relay signals to the body through a peripheral nervous system, with many neuron subtypes, including serotonergic, GABAergic, dopaminergic, octopaminergic, cholinergic, and glutaminergic neurons ([@bib53]; [@bib54]; [@bib9]; [@bib55]; [@bib56]; [@bib11]; [@bib57]). In addition, planarian cell atlas projects recently revealed the existence of \~50 distinct types of neurons, pointing to considerable complexity of regulation for producing and maintaining neurons through ongoing differentiation ([@bib21]; [@bib72]). Planarian tissues are maintained and regenerated by *piwi-1+* neoblast stem cells, a mesenchymal cell population found in a parenchymal region and constituting the animal's only proliferative cells. Transcriptional profiling and candidate approaches have identified subpopulations of neoblasts specified for participation in distinct tissue lineages including a subpopulation of TSPN+ neoblasts that can give rise to all cell types ([@bib39]; [@bib13]; [@bib14]; [@bib82]; [@bib7]; [@bib104]). Neural progenitors have been identified as neoblast subpopulations expressing either pro-neurogenic transcription factors or transcription factors expressed in unique differentiated neurons, and some have been assigned to particular lineages through RNAi ([@bib96]; [@bib47]; [@bib21]; [@bib72]; [@bib78]). Thus, neoblasts and their differentiating progeny sustain ongoing neurogenesis in the absence of injury as well as in regeneration of a new head.

Brain regeneration in planarians is a robust process that always ensures a proper restoration of relative neuron abundance in the animal. Decapitation triggers waves of wound-induced signals, bursts of proliferation, a patterning process to sense missing tissues, and differentiation of new tissues within an outgrowing blastema. Planarians do not grow appreciably as they regenerate, so the end of regeneration is characterized by a return to uninjured cell and tissue proportionality with respect to body size ([@bib60]; [@bib28]). In addition, the regeneration process involves re-scaling and integrating pre-existing tissues with new tissues. For example, regenerating head fragments reduce the size of their brain while they form a small tail blastema until they reach appropriate proportionality. The robustness of the regeneration process suggests first that the system is well suited for identifying subtle phenotypes affecting adult neurogenesis. Secondly, the planarian's ability to attain and maintain a predictable relative abundance of neurons suggests the process is under both positive and negative control.

We report here the identification of a Tec non-receptor tyrosine kinase gene through RNAi screening in planarians that limits neuron abundance in regeneration and homeostatic tissue maintenance. Analysis of *tec-1*'s mechanism of action reveals it is unlikely to control the process of differentiation, but instead negatively regulates neuron survival. These results suggest that like neural development, both regeneration and stem-cell dependent adult neurogenesis both involve an initial overproduction of new neurons and identify a new factor involved in limiting the specific amplification of cells produced by adult neurogenesis.

Results {#s2}
=======

*tec-1* limits the regeneration of brain neurons {#s2-1}
------------------------------------------------

To identify negative regulators of neuronal regeneration in planarians, we conducted an RNAi screen of \~50 kinases and receptors with expression enriched in neoblasts ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). In order to quantitatively measure effects on neuronal regeneration, we used a histological assay for staining and enumerating chemosensory neurons of the brain expressing the *cintillo* gene homologous to the Degenerin superfamily of sodium channels (*cto*, [Figure 1A](#fig1){ref-type="fig"}). *cto*-expressing neurons are arranged in a stereotyped pattern in close proximity to the lateral brain branches, and their numbers scale with overall animal and brain size. Because these cells adopt a planar and well-spread configuration, quantification of whole animal *cto* cell number through automated image segmentation is straightforward and robust ([@bib60]; [@bib28]). Decapitated animals which initially lack *cto*+ cells regenerate them as they form a new head until an appropriate ratio of *cto*+ cells to body size is attained. We treated animals with dsRNA and amputated to produce head, tail, and trunk fragments that were fixed and stained in 96-well mesh plates after regeneration. In order to maximize the effects of RNAi, regenerating trunk fragments were amputated again and scored for their ability to regenerate *cto+* cells after the second round of regeneration, whereas tail and head fragments were only fixed and scored after a single round of regeneration ([@bib74]). After imaging, numbers of *cto+* cells and total animal area were measured using a CellProfiler pipeline, and differences in relative *cto*+ cell regeneration due to RNAi treatment were determined by computing a normalized log2-fold change ratio as compared to groups treated with a non-targeting dsRNA (*C. elegans unc-22*). Treatment with a positive control dsRNA targeting *ndk*, a factor that restricts head regionalization in planarians ([@bib8]), produced increased numbers of *cto*+ cells in the screen. The screen identified four genes whose inhibition reduced numbers of *cto*+ cells attained through regeneration (log2FC \< −1 and padj \<0.05), though several other treatments caused smaller *cto+ *cell decreases that did not meet the false-discovery corrected statistical cut-off ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Because these factors could either be required for expression of *cto* in mature neurons, be required for differentiation from neural progenitors, or be required for maintenance of neoblasts in general, we did not pursue any further analysis of them here ([Figure 1B](#fig1){ref-type="fig"}).

![An RNAi screen identifies regulators of neuronal regeneration.\
(**A**) Design of RNAi screen. Animals were fed over several weeks, challenged to regenerate after head and tail amputation, and then fixed and stained for *cto* expression using Hoechst as a counterstain to detect total animal tissue (heads and tail fragments fixed at d23, while and regenerating trunks were fed dsRNA at d10 then amputated again the following day and then fixed 12 days later). Numbers of *cto*+ cells were enumerated using CellProfiler and normalized to animal size as measured by Hoechst area in CellProfiler. (**B**) Log2-transformed fold changes of area-normalized *cto-*cell number were determined by comparison to similar fragments treated with control dsRNA, combined across head, trunk and tail fragment types for each dsRNA treatment and plotted in ascending order of average log2-fold change. Dots represent log2-fold change for each regenerating fragment, with boxplot shading representing average log2-fold change compared to controls. Knockdown of *tec-1* increased *cto*+ cell number more than *nou-darake* positive control on average. Dotted line indicates log2FC for control RNAi conditions. (**C**) To measure *tec-1* RNAi's effect on head regeneration and injury-induced remodeling, animals were fed dsRNA for 2 weeks before decapitation and allowed to regenerate for 16 days. To measure the effects of *tec-1* inhibition in homeostasis, animals were fed dsRNA for 60 days and fixed without injury. An increase in *cto*+ cell number was detected in all contexts. \*\*\*p\<0.001 by two-tailed t-test. Scale bars: 100 μm.](elife-47293-fig1){#fig1}

We sought to uncover factors that negatively regulated *cto*+ cell production and found one factor, a Tec-family kinase (*tec-1)*, whose inhibition caused a statistically significant increase in abundance of *cto*+ cells ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). To verify these effects, we inhibited *tec-1* in a similar design as the screen but with an increased sample size. These experiments confirmed that inhibition of the Tec homolog resulted in a robust \~50--100% increase to the number of *cto*+ cell numbers, which had approximately normal spatial distribution in the animal ([Figure 1C](#fig1){ref-type="fig"}). *tec-1* knockdown led to an increase in *cto*+ cell number both in decapitated animals regenerating an entirely new head and also in head fragments undergoing tissue remodeling ([Figure 1C](#fig1){ref-type="fig"}). This increase in relative *cto+* cell abundance was not due to a change in overall animal size, but rather to an increase in absolute numbers of *cto+* cells ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Regeneration of head and tail fragments involves extensive stem cell-dependent production of new brain neurons and control of the rates of cell death, as well as injury-induced signals that initiate the process. Uninjured planarians undergo perpetual homeostatic regeneration of all cell types, including neurons of the brain, but lack expression of injury induced factors. In order to test whether *tec-1*'s function depended on wound signaling, we fed animals *tec-1* dsRNA for 60 days in the absence of injury and found that *cto*+ cell number increased to a similar extent as in amputated fragments ([Figure 1C](#fig1){ref-type="fig"}). Therefore, *tec-1* functions to limit numbers of neurons independent of injury signaling.

To examine a possible redundancy of function, we scanned the *Schmidtea mediterranea* genome and transcriptome and identified a second Tec family kinase, which we named *tec-2* ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Inhibition of *tec-2* by RNAi did not increase *cto*+ cell numbers or enhance the effects of *tec-1* RNAi ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Therefore, *tec-2* likely does not act redundantly with *tec-1* for control of *cto+* cell abundance.

RNAi phenotypes that modify body patterning (such as *nou darake* RNAi) can result in production of excess *cto+* cells as a consequence of axis transformation ([@bib25]; [@bib31]; [@bib67]; [@bib38]; [@bib83]), so we tested whether *tec-1* could operate similarly. Whereas *ndk* inhibition increased *cto*+ cell number concomitant with increasing the size of the brain ([@bib8]), *tec-1* inhibition did not alter brain size ([Figure 2A](#fig2){ref-type="fig"}). Instead, *tec-1* RNAi, but not *ndk* RNAi, significantly increased the number of *cto+* cells normalized to brain size. The observation that *tec-1* inhibition increased numbers of *cto+* neurons without altering the relative size of the head or brain raised the question of how such animals physically pack increased neurons. To clarify how planarian brains could increase the number of cells without altering their overall size, we mapped the 3D positions and sizes of *cto+* cells in control versus *tec-1(RNAi)* animals, and determined their nearest-neighbor distances and cell body volumes using Fiji/ImageJ ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). *tec-1* inhibition decreased the average nearest-neighbor distance of *cto*+ cells and also the average volume of each cell as measured by *cto *m*RNA *distribution. Therefore, *tec-1* influences *cto+* cell abundance and size.

![*tec-1* inhibition increases chemosensory neuron abundance but not head regionalization.\
(**A**) Animals were fed dsRNA for 2 weeks, amputated to remove heads and tails, and allowed to regenerate for 16 days. FISH was performed on trunk fragments to simultaneously measure *cto+* chemosensory neurons and *chat+* cholinergic neurons that allow visualization of the brain. Effects on the brain:body size and density of *cto+* cells normalized to brain size were quantified. *ndk* RNAi resulted in an increase in brain:body size but not in numbers of *cto*+ cells normalized to brain size. By contrast, *tec-1* RNAi increased density of *cto*+ cells within the brain without increasing the proportion of the body axis occupied by the brain. (**B**) *tec-1* RNAi did not strongly affect the expression of anterior-posterior positional control genes *notum, ndl-3,* and *wntP-2* as measured by WISH (images representative for 27/27 animals probed). Scale bars: 100 μm.](elife-47293-fig2){#fig2}

To confirm a lack of overall changes to body regionalization in *tec-1(RNAi)* animals, we examined positional control genes whose expression demarcates distinct body territories. *ndl-3* and *wntP-*2 expression was not appreciably altered in *tec-1* RNAi treatments that result in excess *cto*+ cells ([Figure 2B](#fig2){ref-type="fig"}). By WISH, *tec-1* inhibition was observed to modestly alter the expression of the anteriorly expressed gene *notum*, but through FISH analysis this effect could be attributed to the expansion of a population of previously identified *notum+chat+* neurons present in the anterior of the brain ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). ([@bib28]). We conclude that *tec-1* limits numbers of *cto*+ cells by altering neuron density rather than participating strongly in body patterning, and that *tec-1* regulates the abundance of more than one type of neuron.

*tec-1* negatively regulates the abundance of many neural cell types {#s2-2}
--------------------------------------------------------------------

In order to test the specificity *tec-1*'s function to limit differentiated cell abundance, we investigated the impact of *tec-1* knockdown on other neural cell types whose abundances could be quantified with high precision. We began by examining neurons expressed more medially within the brain compared to chemosensory neurons. *glutamic acid decarboxylase* (*gad*) is expressed in GABAergic neurons in the ventral-medial and dorsal-lateral CNS ([@bib56]). Neurons in these domains have distinct progenitor populations expressing *nkx2.1* and *tcf1* respectively ([@bib15]; [@bib7]). Inhibition of *tec-1* increased the total number of GABAergic cells and also numbers of cells within both domains ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), suggesting that *tec-1*'s activity is not restricted to a single brain region or a specific neuronal lineage. To confirm this, we quantified cells found throughout the brain which expresses the neuropeptide precursor-encoding gene *pyrokinin prohormone-like 1* (*ppl-1*) ([@bib11]). Cephalic *ppl-1+* cells increased in abundance after *tec-1* knockdown ([Figure 3A](#fig3){ref-type="fig"}). *ppl-1* is also expressed prominently in neurons of the pharynx, but these cells were unaffected by *tec-1* RNAi ([Figure 3B](#fig3){ref-type="fig"}), indicating *tec-1* does not regulate abundance of all neurons throughout the animal. We additionally examined serotonergic neurons in the CNS marked by *serotonin transporter* (*sert*), which have a defined progenitor cell type ([@bib16]; [@bib44]), and *dd17258*+ neurons expressed in a domain similar to *cto*+ cells ([@bib21]). We observed that the numbers of both of these populations increased upon *tec-1* inhibition. To test whether *tec-1* might act exclusively within the CNS, we quantified the density of nociceptory *trpA*+ neurons ([@bib100]; [@bib3]) and peripheral cholinergic *chat*+ neurons ([@bib57]) of the in the PNS and found that *tec-1* RNAi increased the abundance of both cell types ([Figure 3A](#fig3){ref-type="fig"}). To obtain more information on the effects of *tec-1* knockdown throughout the body axis, we also sought neuron cell types distributed throughout the body and with densities and abundances amenable to whole-animal enumeration. We selected four such cell types that had been identified in a prior scRNAseq cell atlas study ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) ([@bib11]; [@bib21]). *tec-1* knockdown increased the density of three of these cell types: *dd2223*+, *dd3733*+, and *spp-4*+ neurons. However, *tec-1* knockdown did not affect the abundance of *dd2723*+ neurons, which are expressed in the CNS and pharynx ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). In addition, we also examined photoreceptor neuron abundance, because *tec-1(RNAi)* animals regenerating a new head sometimes produced disorganized eyes ([Figure 3B](#fig3){ref-type="fig"}). Despite affecting eye morphology, *tec-1* inhibition did not modify the number of photoreceptor neurons. Together, we found that *tec-1* inhibition increased the abundance of 10 of 13 neuron markers investigated, indicating that *tec-1* negatively regulates the abundance of many but not all types of neurons within the central and peripheral nervous systems.

![*tec-1* inhibition increases abundance of several CNS and PNS neurons.\
(**A-C**) Animals were fed dsRNA for two weeks, amputated to remove heads and tails, and allowed to regenerate for 15 days. Regenerating head fragments were fixed and stained for *gad* expression, regenerating tail fragments were stained for *ppl-1, trpA*, *opsin/tyrosinase*, *glut*, or *if-1/cali* expression, and regenerating trunks were stained for *chat* or *dd17258* expression. Cell types amenable to total animal enumeration were quantified by normalizing cell number to body size by dividing by the square root of whole animal area (*gad*+, brain and pharynx *ppl1*+, brain *sert*+, *dd17258*+, *opsin*+ cells). Abundances of cell types too numerous for whole-body counting were quantified by manually scoring cell numbers in a region of interest and normalizing to the area of that region (*trpA*+ cells were scored in an anterolateral region, peripheral *chat+* neurons scored in a postpharyngeal ventromedial region, *if-1*+;*cali*, and *glut+* cells scored within the brain defined by Hoechst staining). (**A**) *tec-1* RNAi animals had increased numbers of *gad*+ neurons, *ppl-1*+ neurons within the brain, *dd17258*+ neurons, *sert+* brain neurons, *trpA*+ peripheral neurons, and *chat*+ peripheral neurons. (**B**) *tec-1(RNAi)* animals regenerated disorganized photoreceptors but had no alteration in *opsin+* cell numbers. Likewise, *tec-1* inhibition did not alter numbers of pharyngeal *ppl-1*+ neurons. (**C**) *tec-1* knockdown decreased the density of *glut*+ and pooled *if-1/cali*+ glial cells in the brain. Significance determined by two-tailed t-tests (\*, p\<0.05; \*\*\*, p\<0.001; n.s. p\>0.05). Images show Hoechst-stained maximum projections except for maximum-projected pharyngeal *ppl-1+* cells shown for clarity overlayed with a single slice of Hoechst-labeled pharynx tissue. Scale bars: 100 μm unless otherwise noted.](elife-47293-fig3){#fig3}

Because many of these effects were identified in brain-localized, anterior cell types, we wanted to understand whether the *tec-1* RNAi phenotype only affected anterior cells. Planarian proliferative cells have differential sensitivities to DNA damage repair and cell death across the A-P axis ([@bib65]). To test a potential influence of axis position on the *tec-1* RNAi phenotype, we determined the A-P position of all *dd2223*+ cells in control and *tec-1* RNAi animals and binned these into anterior and posterior regions ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). *tec-1* inhibition increased the abundance of *dd2223*+ neurons in both the anterior and posterior of the animal. Furthermore, *tec-1* RNAi did not alter the relative proportion of anterior versus posterior *dd2223*+ neurons. Together, we conclude that *tec-1* can act equivalently on neurons independent of body position.

We also wanted to determine whether *tec-1* exerts its influence equally on distinct cell types. To test this, we stained *tec-1(RNAi)* and control animals simultaneously for *cto* and either *gad* or *ppl-1*, which are expressed in different areas of the brain. Counting two neuron populations at once allowed direct comparisons of the *tec-1* RNAi phenotype's expressivity for each animal. *tec-1* inhibition increased numbers of these neuron cell types to the same extent without affecting *gad:cto* or *ppl1:cto* cell ratios ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Therefore, *tec-1* appears to affect multiple neuron type abundances concordantly.

We next sought to determine whether excess neurons produced in *tec-1(RNAi)* animals had features of normal neurons. We noticed that riboprobes detecting *cto* mRNA primarily stained the cell body, but high magnification imaging revealed some detection of signal in processes extending laterally from these bodies, putatively related to axonal or dendritic regions. A similar proportion of *cto+* cells had such processes in control versus *tec-1(RNAi)* animals ([Figure 3---figure supplement 4A](#fig3s4){ref-type="fig"}). We also used alpha-tubulin staining to examine overall innervation patterns. In this assay, *tec-1(RNAi)* animals displayed a qualitative increase in size of nerve bundles, particularly evident in the transverse commissural fibers joining the nerve cords along the ventral side of the animal ([Figure 3---figure supplement 4B](#fig3s4){ref-type="fig"}, 6/7 animals examined). Treatments disrupting synaptic transmission can cause failure of neuron regeneration in planarians ([@bib32]), suggesting that the excess neurons in such animals may be functional.

We reasoned that *tec-1* might control cell abundance specifically within a subset of CNS and PNS neurons or more generally throughout the animal. Neither *collagen*+ body wall muscle cells nor epidermal nuclei were found to have statistically significant changes in density after *tec-1* inhibition ([Figure 3---figure supplement 5A](#fig3s5){ref-type="fig"}), suggesting the specificity of *tec-1*'s cell number control activity to the nervous system. We also examined animals stained for broad markers of excretory and intestinal tissue ([Figure 3---figure supplement 5B](#fig3s5){ref-type="fig"}). There were not obvious increases in expression of either marker of these tissue types.

In addition, we also examined non-neuronal cells in the CNS characterized as astrocyte-like glial cells ([@bib77]; [@bib99]). *tec-1* inhibition decreased the density of cells expressing pooled glial markers *intermediate filament 1* (*if-1*) and *calamari* (*cali*) as well as those expressing *glucose transporter* (*glut)* ([Figure 3C](#fig3){ref-type="fig"}). The functions for planarian glial cells are not yet characterized, but these cells could have a role in neuron surveillance.

*tec-1* suppresses neuronal cell number by regulating cell survival {#s2-3}
-------------------------------------------------------------------

We next sought to determine how *tec-1* exerts its negative regulatory function on neuron abundance. Differentiated cells are produced continually from neoblasts in adult planarians, so that increases to numbers of differentiated cells could either arise from an increase in stem cell-dependent tissue production or through decreases in the death of differentiated cells. Because *tec-1* knockdown broadly increased neuronal numbers while decreasing glial numbers, and it is known that neurons and glial cells can arise from common progenitor cells in some contexts in other organisms, we initially hypothesized that *tec-1* might control a differentiation switch at some early point in neural specification ([@bib48]; [@bib30]).

To better understand the dynamics of *tec-1*'s effects on regeneration, we measured *cto*+ cell abundance over time during head regeneration after decapitation and during remodeling of head fragments ([Figure 4A](#fig4){ref-type="fig"}). In decapitated *tec-1(RNAi)* animals regenerating a new head, the rate of production of new *cto*+ cells was not altered at early times (4 days), but abundance of *cto*+ cells was higher after a week of regeneration (8 days) and reached a maximum point at 16 days. We also confirmed through WISH that *tec-1* is expressed broadly in the animal and throughout regeneration from day 2 to day 12 post-amputation without undergoing discernable regeneration-induced expression changes ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Given this expression and that *tec-1* affects neuron density in both regeneration and homeostasis, it is likely this gene functions constitutively to regulate neuron numbers. To test for the perdurance of the phenotype in regeneration, we measured *cto*+ cell number up to 4 weeks after decapitation and found that *cto* cells had reached a steady-state maximum by two weeks post-amputation ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). In *tec-1(RNAi)* head fragments undergoing tissue remodeling, the maximal *cto*+ cell abundance phenotype was observed somewhat earlier, by 4 days, and persisted ([Figure 4A](#fig4){ref-type="fig"}). The progressive nature of the phenotype in decapitated regenerating animals suggests that *tec-1* is unlikely to regulate rates of differentiation commonly across all timescales and conditions. However, it remained possible that rates of neuron differentiation are maximal during early head regeneration, while *tec-1* could restrict rates of differentiation in a process common to the contexts of late head regeneration, head remodeling, and homeostatic maintenance.

![*tec-1* inhibition does not increase rates of neuron differentiation.\
All animals were fed dsRNA for 2 weeks before surgeries as indicated by cartoons. (**A**) Time courses of *cto+* cell number in regeneration of a new head (left) or remodeling of a pre-existing head (right). Each data point represents sample size of between 4 and 12 animals. (**B**) Animals were transtioned into high-salt water one week before surgery, and either whole animals (day 0) or head fragments (days 2 and 4) were soaked in BrdU for 4 hr. Heads fragments were fixed at days 6, 8, 10, and 12 post-amputation. Co-staining of control versus *tec-1(RNAi)* animals for *ppl-1* mRNA and BrdU showed no detectable increase in numbers of BrdU+*ppl-1*+ cells at any time point (left). Single confocal slices show staining of BrdU and *ppl-1* in day 12 animals (right). White arrows show colocalization. (**C**) Regenerating tail fragments were fixed at 2, 4, 8, or 12 days post injury and stained with FISH to detect *piwi-1* and *coe* or *pax6* transcription factors, which label broad neuronal progenitors, or *pitx* transcription factor, labeling progenitors of serotonergic neurons. Single confocal slices show staining of transcription factors, *piwi-1,* and Hoechst counterstain in day 12 animals. No significant differences in numbers of neural progenitor cells were detected (\*\*\*, p\<0.001, n.s. p\>0.05 by two-tailed t-test, error bars represent standard deviation). Scale bars: 100 μm.](elife-47293-fig4){#fig4}

To test this possibility, we designed a BrdU labeling strategy to test for possible effects of *tec-1* inhibition on the rate of neuron differentiation. We chose to investigate regenerating head fragments undergoing brain remodeling because *tec-1* inhibition caused a rapid attainment of excess neurons compared to control animals, so we reasoned these fragments would provide a context in which *tec-1*-dependent regulation is prominent. Neoblasts are the only proliferative cells in adult planarians, so a pulse of BrdU initially marks these cells, followed by labeling their newly-born post-mitotic descendants ([@bib52]). In order to measure rates of neuron production, we soaked animals with BrdU earlier on same the day of amputation (d0) or at 2 or 4 days after amputations to generate head fragments, then fixed the animals at 6, 8, 10 and 12 days post-amputation in order to detect BrdU incorporation into new mature neurons ([Figure 4B](#fig4){ref-type="fig"}). We chose to analyze BrdU incorporation into *ppl-1+* brain neurons because they are under robust control by *tec-1* ([Figure 3A](#fig3){ref-type="fig"}), and they are more numerous than cell types such as *cto+* or *gad*+ neurons, thus maximizing the ability to detect any influence of *tec-1* on neuron differentiation given possible inefficiencies in BrdU label uptake. However, numbers of *ppl-1*+BrdU+ cells were not significantly different in control versus *tec-1(RNAi)* animals over a range of timepoints of BrdU pulsing and fixation in regeneration. These data indicate that *tec-1* inhibition can increase numbers of neurons without modifying rates of differentiation, pointing instead to a function in controlling neuron survival.

A model in which *tec-1* controls neuronal survival would predict that *tec-1* does not influence the abundance of neural progenitor cells that are the intermediates between pluripotent neoblast stem cells and differentiated neurons ([Figure 4C](#fig4){ref-type="fig"}). *coe* encodes a transcription factor expressed in a subpopulation of *piwi-1+* neoblasts as well as in a variety of differentiated neurons, and its inhibition reduces the abundance of several types of neurons, including *gad*+ and *cto*+ neurons ([@bib13]; [@bib14]). *tec-1* inhibition did not alter numbers of *coe+piwi-1*+ cells in a timeseries between 2 and 12 days of head regeneration, despite detection of an overall decreasing abundance of such progenitors in both control and *tec-1(RNAi)* animals over time as regeneration proceeds. To confirm these observations, we examined a subpopulation of *piwi-1+* neoblasts expressing the proneural transcription factor *pax6* ([@bib82]) and found that its abundance was also unaltered by *tec-1* inhibition in the same time period. *coe* and *pax6* mark broad classes of neural progenitors, so we also sought to test the abundance of neural progenitors that produce individual neural cell types. *pitx* transcription factor is required for production of *sert*+ serotonergic neurons and *pitx* is expressed within a *piwi-1+* neoblast subpopulation proposed to be the progenitors for these cells. Although *tec-1* inhibition increased the abundance of *sert*+ neurons in the brain ([Figure 3A](#fig3){ref-type="fig"}), *tec-1* RNAi did not alter numbers of *pitx+piwi-1*+ serotonergic neuron progenitors near the brain ([Figure 4C](#fig4){ref-type="fig"}).

We next examined *tec-1* expression by double-FISH to determine whether this gene could be expressed preferentially within neurons, neural progenitors, or other cell types. However, we detected *tec-1* FISH signal not only within each type of neuron tested (*cto, gad, ppl-1*) but also within *pitx*, *coe,* or *pax6A*-expressing cells, neoblasts or their differentiating progeny marked with anti-PIWI-1 antibody, and in *if-1;cali*+ glial cells ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Therefore, *tec-1* is a broadly expressed gene that exerts a specific effect on neuronal cell density. Consistent with these observations and the specificity of the *tec-1(RNAi)* phenotype, *tec-1* inhibition did not modify numbers of H3P+ mitotically active cells in response to injury ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Taken together, these results support the model that *tec-1* does not regulate the process of neuronal differentiation or control a switch between neuronal and glial specification.

In light of these results, we reasoned that *tec-1* might function to activate cell death specifically of CNS and PNS neurons. Uninjured planarians undergo a basal rate of homeostatic cell death thought to occur across tissue types as older cells die off and require stem cell-dependent replacement, and amputation triggers a systemic elevation of cell death of differentiated cells as part of the tissue remodeling process ([@bib66]). We used TUNEL staining on remodeling head fragments to test whether *tec-1* promotes cell death and found that *tec-1* RNAi reduced but did not eliminate numbers of TUNEL+ cells ([Figure 5A](#fig5){ref-type="fig"}). This observation is consistent with a model in which *tec-1* promotes cell death of some but not all cells.

![*tec-1* promotes cell death and limits survival of new neurons.\
Animals were fed dsRNA for 2 weeks before amputation to measure numbers of dying cells and persistence of regenerated chemosensory neurons after lethal irradiation. (**A**) Head fragments were TUNEL stained 72 hr after injury and numbers of TUNEL+ cells normalized to fragment area quantified to find that *tec-1* inhibition resulted in diminished numbers of dying cells. (**B**) Amputated trunk fragments were allowed to regenerate for 6 days, treated with 6000 rads of X-rays to eliminate neoblasts and subsequent neuron differentiation, then fixed at the indicated times post-injury, and numbers of *cto+* cells detected and counted by FISH and normalized to brain length determined by Hoechst staining. Schematic shows predicted effects of lethal irradiation on population abundances (blue shading) for cells involved in producing new *cto+* neurons in head regeneration: neoblasts, neural progenitors, and differentiated CNS neurons after irradiation during head regeneration over the course of days. In control animals, the density of *cto*+ neurons (red) decreased between four and six days after irradiation (bracket). By contrast, *tec-1(RNAi)* animals had normal numbers of newly formed *cintillo+* cells, *cto+* number is not significantly greater than controls at d10 post amputation, but is significantly greater than controls two days later. Each data point represents sample size of between 4 and 9 animals. (**C**) Model of normal neuronal production, where *tec-1* acts to cull excess neurons in homeostasis and regeneration (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s. p\>0.05 by two-tailed t-test, error bars represent standard deviation). Scale bars: 100 μm.](elife-47293-fig5){#fig5}

We hypothesized based on the above results that *tec-1* might promote cell death in a fraction of newly born neurons. The requirement of *tec-1* under conditions of both homeostasis and regeneration would then suggest that, as in embryonic development in other organisms, regenerated brain neurons in planarians undergo an initial overproduction followed by rapid cell death. The regeneration of a new head in decapitated animals represented a condition in which we reasoned this phenomenon would be most easily detected, because in that context the new production of brain neurons is synchronized by amputation. However, detailed time course analysis of new neuron production in such animals has not yet identified such overproduction, suggesting that ongoing neuron production during the \~1--2 weeks of head regeneration might mask these effects. Therefore, we sought a means to isolate the fates of a limited cohort of neurons produced only within a narrow time window after amputation. To do this, we used lethal irradiation early during head regeneration to eliminate neoblasts acutely, followed by a timeseries of fixation and staining, to measure the survival of a cohort of neurons produced only within in a specific time frame. After *tec-1* inhibition and head amputation, planarian fragments were irradiated 6 days later then fixed in a time series in the absence of proliferating cells. Staining these animals with a *piwi-1* riboprobe 2 days after irradiation showed complete elimination of neoblasts by this time ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In control animals, *cto*+ cell number decreased between days 10 and 12 post-amputation, consistent with the prediction of initial overproduction ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). *tec-1(RNAi)* animals did not produce significantly more *cto+* cells at day 10 compared to controls but did not undergo the day 12 decrease in *cto*+ cells. These data confirm that *tec-1* does not influence rates of cell production but instead strongly suggest that *tec-1* promotes the death of newly born neurons in order to limit the abundance of cells produced through adult neurogenesis ([Figure 5C](#fig5){ref-type="fig"}).

Discussion {#s3}
==========

Here we identify the conserved gene *tec-1* as a potent and novel negative regulator of stem cell-dependent adult neurogenesis in *Schmidtea mediterranea*. Completion of regeneration and homeostatic maintenance requires control of both the rates of new cell differentiation and also control of cell survival ([@bib43]). Several positively acting factors contribute to differentiation of new neurons in planarians. Injuries trigger expression of the *runt-1* transcription factor within neoblasts, required for producing normal numbers of *trpA*+ brain cells, eyes, and other cells. Other fate determinants appear to act constitutively to control differentiation or expression within distinct neuronal populations ([@bib100]; [@bib13]; [@bib16]; [@bib44]; [@bib82]; [@bib96]; [@bib15]; [@bib47]; [@bib7]; [@bib21]).

By contrast, fewer regulators of cell death have been identified in planarians and these appear to regulate multiple lineages. Inhibition of *bcl2-1*, a conserved antiapoptotic factor, causes a rapid increase in systemic cell death and subsequent animal lysis ([@bib66]). *jnk* and *yorkie* inhibition both decrease cell death and increase numbers of *cto*+ cells relative to overall body size in decapitated head fragments ([@bib2]; [@bib40]). However, in both of these phenotypes, an increase in neuronal number is linked to an increase in overall brain size and is in a context in which the brain normally undergoes reduction through injury-induced remodeling. Based on *tec-1's* specificity for neural cells and utilization in both regeneration and homeostasis, we suggest it operates in a distinct pathway ([Figure 5C](#fig5){ref-type="fig"}).

We envision at least two possible mechanisms by which *tec-1* facilitates neuronal cell death based on differing sites of action. *tec-1* could act cell autonomously within neurons to promote cell death or alternatively could be necessary within a distinct cell population involved in neuron killing and/or engulfment. The broad expression of *tec-1* throughout multiple tissues would be consistent with either possibility ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Cell atlas projects also found that *tec-1* is expressed broadly but is moderately enriched in neural progenitors, consistent with the first possibility, but also within intestine and *cathepsin*+ cells that could have uncharacterized roles in neuron homeostasis ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}) ([@bib21]; [@bib72]). Future work delineating *tec-1* signaling targets could clarify this aspect of *tec-1's* anti-survival function.

Tec family kinases (TFKs) are non-receptor tyrosine kinases similar to Src family kinases. TFKs are perhaps best known for signaling downstream of antigen receptors in hematopoietic differentiation and lymphomas ([@bib5]; [@bib76]). However, they are also involved in a wide variety of signaling pathways downstream of GPCRs, integrins, and both receptor and non-receptor tyrosine kinases, and are known to regulate apoptosis, cell adhesion, and the actin cytoskeleton in addition to differentiation ([@bib90]). In mammals, a majority of studies have found that Tec kinases such as BTK are essential for the survival or proliferation of immune cells, including phagocytic cells ([@bib91]; [@bib34]; [@bib45]; [@bib61]), suggesting that planarian *tec-1* might not act cell autonomously within neurons to promote death. Alternatively, in some contexts, Tec kinases have been reported to function as cell autonomous tumor suppressor genes that promote p53-mediated cell death pathways ([@bib73]). Within the mammalian brain, chemical inhibition of the Tec-family kinase BTK increased brain cell survival after ischemic brain injury, an effect attributed to the modification of macrophage activity ([@bib33]). It is possible that Tec kinases could regulate conserved functions in adult neurogenesis to control of neuron abundance in other organisms.

The requirement for *tec-1* for neuron suppression in regeneration and homeostasis in planarians additionally suggests that developmental cell death of neurons might be a common feature of adult neurogenesis across species. Cell death is extensively used throughout the animal kingdom to sculpt the developing nervous system, from nematodes to mammals ([@bib102]). Among well-studied invertebrates, adult neurogenesis has been detected in *Drosophila* within the medulla cortex, where it can also mediate injury repair ([@bib20]). However, the bulk of neurogenesis in *C. elegans* and *Drosophila* occurs at embryonic or larval stages prior to adulthood, so the precise roles of cell death for adult neurogenesis and ways they may be conserved across distant phyla have yet to be fully elucidated. Based on TUNEL staining and the observation that mouse mutants defective for cell death in the nervous system overproduce neurons in multiple regions of the brain, developmental cell death of neurons is integral to adult neurogenesis in mammals ([@bib6]; [@bib101]; [@bib88]), and cell death after differentiation has been confirmed through direct observation ([@bib71]). Regulation of cell death at the level of neural progenitors may control brain morphology by preventing hyperplasia or may define where crucial morphogenic signals are expressed ([@bib26]; [@bib58]; [@bib102]), while regulation of the survival of newly formed neurons has been proposed to provide mechanisms to ensure proper connectivity or limit interneuron cell number ([@bib86]; [@bib18]). During brain development, preventing neurotransmitter secretion results in assembly of a mostly normal brain followed by massive neuronal apoptosis, suggesting that regulated cell death plays a role in the maturation of newly-differentiated neurons during embryogenesis ([@bib98]). Reliance on neurotransmitter signaling to promote survival of immature neurons is also used extensively in murine adult neurogenesis ([@bib69]), among other cell-type specific mechanisms ([@bib70]). Many of these pathways converge on promoting survival through BCL2 family members, while death is promoted by Bax and Bak ([@bib49]; [@bib84]; [@bib88]; [@bib79]; [@bib50]). Therefore, inhibitors of core cell death pathways have been proposed as therapeutic agents to assist in damage repair after brain injury ([@bib17]; [@bib42]), though these would be expected to have substantial effects on other organ systems. If the ability of Tec kinases to limit neuron production ultimately proves to be conserved, they would be potential targets for enhancing neural repair in other species.

The identification of negative regulators of neurogenesis may be an important step in understanding neural regeneration in planarians and other systems. Suppressors of mTOR and JAK/STAT signaling in vertebrates can be inhibited to increase axon growth after spinal cord injury in laboratory conditions ([@bib62]; [@bib41]; [@bib89]). The JAK/STAT inhibitors Socs3 and Sfpq attenuate axonal regrowth in the optic nerve of mice and zebrafish ([@bib85]; [@bib89]; [@bib19]). Additionally, while canonical Wnt signaling appears to promote neural regeneration in vertebrates ([@bib103]; [@bib87]; [@bib63]), non-canonical Wnt signaling inhibits axon guidance and growth ([@bib59]). A more complete understanding of negative inputs into adult tissue homeostasis could provide new and more specific targets for the enhancement of neural tissue repair or treatment of degenerative disease ([@bib94]). Our results suggest that planarians, which undergo extensive homeostasis of the CNS in adulthood, can be a model for efficiently identifying such negative regulators of adult neurogenesis.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                     Designation                                             Source or\               Identifiers                                                   Additional\
  (species) or\                                                                             reference                                                                              information
  resource                                                                                                                                                                         
  --------------------------------- ------------------------------------------------------- ------------------------ ------------------------------------------------------------- -----------------
  Gene (*Schmidtea mediterranea*)   Tec-1                                                   Planmine                 dd_Smed_v6_4818_0\_1                                          

  Antibody                          Polyclonal rabbit anti-digoxigenin-POD, Fab fragments   Sigma/Roche              \# 11207733910\                                               1:2000 dilution
                                                                                                                     RRID: [AB_514500](https://scicrunch.org/resolver/AB_514500)   

  Antibody                          Polyclonal rabbit anti-fluorescein-POD, Fab fragments   Sigma/Roche              \#11426346910\                                                1:2000 dilution
                                                                                                                     RRID: [AB_840257](https://scicrunch.org/resolver/AB_840257)   

  Antibody                          Polyclonal rabbit digoxigenin-AP                        Sigma/Roche              \#11093274910                                                 1:4000 dilution

  Antibody                          Rat polyclonal Anti-BrdU                                Abcam                    6326                                                          1:1000 dilution

  Antibody                          Rabbit monoclonal anti-phospho-ser10 Histone H3         Cell Signaling           D2C8                                                          1:3000 dilution

  Antibody                          Mouse monoclonal anti-TUBULIN-ALPHA AB-2                Thermo/Fisher            MS581P1                                                       1:1000 dilution

  Commercial assay or kit           TUNEL labeling kit                                      Thermo/Fisher            EP0162                                                        N/A

  Antibody                          Goat polyclonal anti-rat HRP                            Jackson ImmunoResearch   112-036-072                                                   1:1000 dilution
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Planarian culture {#s4-1}
-----------------

Asexual strain CIW4 of the planarian *Schmidtea mediterranea* were maintained in 1 × Montjuic salts at 19°C as described ([@bib68]). Animals were fed a liver paste and starved for at least 7 days before experiments.

Screen {#s4-2}
------

60 putative regulatory molecules were selected by analysis of the planarian transcriptome to identify a set with expression detected in neoblasts after FACS sorting ([@bib36]), (into populations of X1 neoblasts in G2/S/M phases, X2 cells comprised of a mixture of G1 neoblasts and G0 newly postmitotic progenitor immediate descendants of neoblasts or other irradiation-sensitive G1/G0 cells, and Xins differentiated cells) with either X1/Xins or X2/Xins expression greater than two or either X1 or X2 FPKM \>3. Genes classified through blastx or panther as receptor tyrosine kinases, protein tyrosine kinases, integrins, GPCRs, or other signaling factors were prioritized. dsRNA was generated through reverse transcription and two rounds of nested PCR with primers indicated (Table S1) and further amplified to add T7 sites for dsRNA production. dsRNA was produced by T7 in vitro transcription, annealing and purification by ethanol precipitation and added to liver as described previously. Animals were fed three times over a week and amputated to remove heads and tails. Head and tail fragments were fixed at 23 days following amputation ('A-score' heads and tails), while trunk fragments were fed again at d10 and amputated to remove heads and tails then regenerating trunk fragments were fixed 12 days later ('B score' trunks). Fixations, fluorescence in situ hybridizations, and Hoechst stainings to detect *cto* expression were carried out as described previously but in 96-well mesh-bottomed plates (Milipore Multiscreen Plates, MANMN4010) incubating in either Multiscreen receiver plates or rectangular 1-well dishes (VWR 73521--420). Stained animals were mounted and imaged at 40x using a fluorescence dissecting microscope to obtain a view of *cto* expression within the head and also at 25x to obtain a Hoechst-stained view of the entire fragment. A CellProfiler pipeline for automated image analysis was developed to quantify numbers of *cto*+ cells and also to measure area of the fragment as detected by Hoechst staining. Automated cell counting was optimized by adjusting the fixed detection threshold and object size range. Processed images were manually inspected for proper segmentation and scored manually in the event of visible errors in automated counting. Numbers of *cto*+ cells scale with animal length, so we normalized *cto* cell number to the square root of animal area as an approximate of animal length. Log2-fold change of normalized *cto* cell number was computed for each specimen by comparison to the average of control RNAi treatments, and these values for all fragment types (A-score heads and tails, B-score trunks), were binned and plotted in R using ggplot2. T-tests comparing area-normalized *cto*+ cell numbers between each RNAi condition and RNAi controls were adjusted for false discovery using the Benjamini-Hochberg method as implemented in R.

Phylogenetic analysis {#s4-3}
---------------------

Protein sequences were aligned using MUSCLE with default settings ([@bib10]). Maximum likelihood analysis was run using PhyML with 100 bootstrap replicates, the WAG model of amino acid substitution, four substitution rate categories, and the proportion of invariable sites estimated from the dataset ([@bib24]; [@bib23]). We used proteins from *Homo sapiens* (hs), *Mus musculus* (mm), *danio rerio* (dr), *Drosophila melanogaster* (dm), and *Caenorhabditis elegans* (ce).

RNAi {#s4-4}
----

RNAi was performed by dsRNA feeding. For RNAi, dsRNA was synthesized from in vitro transcription reactions (NxGen, Lucigen). dsRNA corresponding to *Caenorhabditis elegans unc-22*, not present in the planarian genome, served as a negative control. Unless noted otherwise, animals were fed a mixture of liver paste and dsRNA six times in two weeks prior to amputation of heads and tails.

In Situ hybridization, Immunostaining and qPCR {#s4-5}
----------------------------------------------

Animal fixation, bleaching, and in situ hybridization were performed as previously described ([@bib64]; [@bib35]). Briefly, fixation, bleaching, and probe synthesis and hybridization were performed according to Pearson et al. Antibody blocking and tyramide development were performed according to King and Newmark. Digoxigenin- or fluorescein-labeled riboprobes were detected with anti-digoxigenin-HRP (1:2000, Roche/Sigma-Aldrich 11207733910, RRID: [AB_514500](https://scicrunch.org/resolver/AB_514500)), anti-fluorescein-HRP (1:2000, Roche/Sigma-Aldrich 11426346910, RRID: [AB_840357](https://scicrunch.org/resolver/AB_840357)). Hoechst 33342 (Invitrogen) was used at 1:1000 as a counterstain. Colorimetric (NBT/BCIP) assays were performed as described and detected with anti-digoxigenin-AP (1:4000, Roche/Sigma-Aldrich 11093274910).

For immunostainings, animals were fixed in 4% formaldehyde. Antibodies against mouse anti-tubulin alpha (1:1000 anti-Tubulin Alpha Neomarkers) or rat anti-BrdU (1:1000 Abcam 6326) and detected with goat anti-mouse HRP (1:150 Life Technologies, T20914) or goat anti-rat HRP (1:1000, Jackson ImmunoResearch 112-036-072) respectively. For histone staining, animals were fixed in Carnoy\'s solution as described ([@bib95]), using tyramide amplification to detect labeling with rabbit anti-phospho-ser10 Histone H3 (1:3000, Cell Signaling D2C8). Rabbit anti-PIWI1 polyclonal antibody (a kind gift of P. Reddien) was used at 1:1000 and detected with goad anti-rabbit HRP (1:150 Life Technologies, T20924).

For qPCR, total animal RNA was collected using Trizol with a tissue homogenizer, reverse transcribed with oligo-dT primers using Superscript II. qPCR was conducted to detect tec-1 mRNA using *tec-1* primers (5'-GTTTTGATGCTAGAATGTTG-3' and 5-TTTGACACACATACTCAAAG-3'), with normalization to a ubiquitously expressed gene gapdh detected with gapdh primers (5\'-TGGTATTCAATTGACCGATACG-3\' and 5\'-GATCGATTACACGGCAACTG-3\') using the delta-Ct method.

BrdU, TUNEL staining, and Irradiation {#s4-6}
-------------------------------------

For BrdU experiments, the concentration of Montjuic salts were gradually increased to 5x one week before surgery. Animals were treated with 0.0625% N‐acetyl cysteine dissolved in 1x Montjuic salts for one minute, washed with 1xMontjuic salts, and incubated in 25 mg/ml BrdU (Sigma) dissolved in 1x salts containing 3% dimethyl sulfoxide for 4 hr either 1 hr before amputation (day 0 soak), or 2 or 4 days post-amputation (day two soak or day four soak respectively). Animals were then maintained in 5x Montjuic salts until fixation on the day indicated in the experiment ([@bib12]; [@bib105]). The BrdU and in situ hybridizations were carried out as previously described above, with all HRP inactivations carried out using formaldehyde (4% in 1xPBSTx for at least 45 min) ([@bib29]). Briefly, animals were rehydrated and bleached in 6% hydrogen peroxide in PBSTx for 3--4 hr on a light box. Following FISH protocol described as above, acid hydrolysis was performed in 2N HCl for 45 min, samples were washed with 1xPBS (twice) then 1xPBSTx (four times), and blocked in PBSTB for 6 hr at room temperature. Primary antibody incubation was performed using rat anti-BrdU antibody (1:1000 in PBSTB, Abcam 6326) overnight at room temperature, followed by 6x washes in PBSTB, and overnight incubation in anti-rat HRP secondary antibody (1:1000, Jackson ImmunoResearch 112-036-072). Tyramide development was performed at room temperature for 1 hr (Invitrogen Alexa568-TSA Kit, tyramide at final concentration of 1:150).

Terminal uridine nick-end labeling (TUNEL) was performed as described by [@bib66], with modifications. Animals were sacrificed in 5% N-acetyl-cysteine in 1 × PBS, fixed in 4% formaldehyde in 1 × PBSTx, and bleached overnight in 6% hydrogen peroxide in 1 × PBSTx. Samples were labeled with DIG-11-dUTP (Roche) by terminal deoxyuridine transferase (TdT) reaction (Thermo) at 37°C for 2 hr, then blocked and incubated overnight in anti-DIG-POD (Roche; 1:2000 in 10% horse serum in 1 × PBSTx) prior to tyramide development (Invitrogen).

To measure neuronal persistence after neoblast ablation, animals were fed and cut as described above. Regenerating trunk fragments were irradiated at 6 days post amputation. Irradiations were carried out in a RS2000 Biological Research Irradiator (Rad Source) at 160 kV over 13'30' for a total, lethal dose of 60 Gy ([@bib4]; [@bib74]). Irradiated fragments were fixed at 8, 10, and 12 days post-amputation.

Image analysis and cell counting {#s4-7}
--------------------------------

NBT/BCIP-stained animals were imaged with a Leica M210F dissecting microscope and a Leica DFC295, with adjustments to brightness and contrast using Adobe Photoshop. Fluorescent-stained animals were imaged with a Leica TCS SPE confocal microscope or a Leica DM5500B compound microscope.

Unless otherwise noted, cell numbers were counted manually or using Image J's Cell Counter analysis tool ([@bib80]; [@bib81]). Cell counts were normalized to animal length or brain length using ImageJ or to the square root of the animal's area calculated by Hoechst staining using CellProfiler ([@bib37]) as noted. *opsin*+ photoreceptor neurons were counted using Imaris x64 7.0.0 (Bitplane AG, Badenerstrasse 682, 8048 Zürich, Switzerland). Surface module was used to define either *opsin*+ or *tyrosinase*+ volume on each eye and then Spots module was used to count nuclei inside these volumes, as previously described ([@bib97]). Data of cell counts from individual samples used for plotting in each figure panel is presented in [Supplementary file 3](#supp3){ref-type="supplementary-material"}.

For analysis of *cto+* cell size and density, z-stacks of animals stained with a *cto* riboprobe were imaged at 20x on a Leica SPE with one micron slices, and *cto*+ cells were segmented in Fiji/ImageJ using the '3D object counter 2.0' plugin after manual thresholding, and the X,Y,Z centroid positions of each cell and cell volume were obtained. Nearest-neighbor analysis was performed by computing the matrix of all pairwise distances between all cell centroids, then for each cell determining the distance between the nearest distinct cell.
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###### Information about genes investigated in RNAi screen.

Table describes ddv6 contig identifier from Planmine, provisional name, and blastx annotation information obtained from Planmine, as well as primers used for cloning cDNA for each gene.

###### RNAi screen data.

Table describes the measurement of *cto* cell abundance after inhibition of each gene. Genes are described by their ddv6 contig identifier from Planmine and with a provisional name. Data from analysis of head, trunks, and tail fragments were pooled to obtain an average value of cto cell number normalized to animal area and standard deviations calculated. Log2-normalized values of (average cto cells/area) are additionally presented. Unadjusted and Benjamini-Hochberg-adjusted p-values are shown from t-tests to compare cto/area measurements between each indicated RNAi condition and control RNAi treatment (*C. elegans unc-22,* 'ctrl').

###### Data used for plotting figure graphs.

Each subpanel or plot is indicated by the name of the corresponding tab in the file. Data of cell counts or normalized cell counts across specimens is indicated.

Data availability {#s7}
=================

All data analyzed during this study are presented in the manuscript and supporting files.
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**Acceptance summary:**

Planarians are organisms possessing extraordinary regenerative abilities, including the complete, functional regeneration of a brain after decapitation. Given the poor capacity of most mammals to regenerate brain tissues, a better understanding of neural regeneration is necessary. Karge and colleagues report on a *tec-1*kinase-mediated negative regulation of planarian neurogenesis. The knockdown of *tec-1* increased the abundance of several types of neurons in the planarian brain during regeneration and homeostasis. Follow-up experiments suggested that *tec-1* functions through facilitating neuronal cell death rather than controlling neuronal differentiation. This work presents an intriguing example of negative regulation of neurogenesis, particularly considering the broad conservation of Tec kinases.

**Decision letter after peer review:**

Thank you for submitting your article \"Tec-1 kinase negatively regulates regenerative neurogenesis in planarians\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Karge and colleagues report on a *tec-1*kinase-mediated negative regulation of planarian neurogenesis. Through an RNAi screen that includes a focal set of kinases, authors noticed that knockdown of *tec-1* increased the abundance of several types of neurons in the planarian brain during regeneration and homeostasis. Follow-up experiments suggested that *tec-1* functions through facilitating neuronal cell death rather than controlling neuronal differentiation, although the exact molecular mechanism remains unknown. This work presents an intriguing example of negative regulation of neurogenesis, particularly considering the broad conservation of Tec kinases.

Essential revisions:

In order to consider this manuscript further, several major issues in terms of the phenotype and interpretation need to be addressed. These are:

1\) The expression of *tec-1* is unclear. While the cell atlas suggests it is broadly expressed and perhaps concentrated in the neuronal progenitors, where is it expressed during regeneration? Does the expression pattern change throughout the regeneration time course? This information is essential, as it should inform the interpretation of phenotypes in terms of whether *tec-1* functions autonomously or non-autonomously. Is *tec-1* co-expressed with any of the neuronal or progenitor types looked at in the paper? Or is it co-expressed with macrophage/phagocytic markers? If FISH is challenging in whole-mount, it is worth trying in sections and dissociated cells.

2\) Control and *tec-1*RNAi animals were compared in terms of differences in differentiation 8 days upon amputation. A BrdU pulse was delivered on day 2 to capture to trace the progeny of cells that were in S phase during the pulse (the duration of this pulse is not specified but should be). The result of this experiment is clear -- no significant difference in the number of BrdU^+^ cells in the ppl+ cell population (which was affected in *tec-1*RNAi much like *cto+* cells). While this work supports the conclusion that *tec-1*RNAi does not affect differentiation of cells in S-phase on day 2, it does not rule out differences in differentiation that may occur prior to or later than this time point. The numbers of progenitors marked by coe, pax6, and pitx were only compared 8 days post amputation, which also does not eliminate the idea that differentiation might be affected by *tec-1* at other time points. Is it known that commitment to differentiated fates only begins on day 2 and that differentiation commitment later than day 2 does not contribute to fully differentiated cell types in a significant way? Or that differentiation rates are constant over time as the worms regenerate? Could the original observation that *tec-1*RNAi animals show larger numbers of *cto+* cells later in regeneration be explained by really early (before day 2) differences?

3\) Does *tec-1* function similarly during regeneration and homeostasis? In Figure 4A, the difference between control and *tec-1*RNAi increases over time, suggesting more neurons should be removed as regeneration progresses. But the system has to reach a steady state eventually, but there is no data showing this. How and when might the steady state be reached in this case? Is it possible that *tec-1*RNAi animals just have a delayed peak of neuronal deaths? In this case, the steady states may be similar between control and RNAi. The comparison of neurons between control and RNAi conditions should be performed after the system reaches a steady state.

4\) In the *tec-1*RNAi the numbers of many neuronal cell types go up, in particular in the brain region, but the size of the brain doesn\'t change. It is clearly visible in the staining that the density of the evaluated neuronal cell types is increased. But how does this work? Is the general cell density in the brain region higher? Are the cells smaller? Or are there compensatory losses of other cell types in the region? Could the detected loss in glial cells be sufficient to compensate?

5\) The authors state that there are no changes in polarity or global patterning genes, but Figure 2B shows a clear increase in the number of notum-expressing cells, and Figure 3B clearly shows disorganized photoreceptors. This suggests that there are definitely some -- possibly subtle -- changes in anterior organization. It would be very interesting to understand whether the change in notum levels could induce this change in responsiveness to apoptotic signals. In addition, there have been some indications that apoptosis is not constant along the A-P axis (e.g. Peiris et al., 2016), and it would be worth taking into consideration whether this might explain some of the observed phenotype.

6\) Is there an anterior bias in the detected neuronal cell increase? Most of the neuronal cell types are evaluated in the anterior region. Only the bottom panel in Figure 3A shows a change in a more posterior region. Are the effects mostly detected in the anterior, or are neuronal cell increases in the posterior just as strong?

7\) Is it possible that *tec-1*RNAi causes a prolonged differentiation? There is a caveat in terms of Figure 4C showing *tec-1*\'s disinvolvement with rate of neuronal differentiation. The regenerating tail fragments were examined at day 8 post-amputation, at which point Figure 4A suggests has only a slight increase in neuronal abundance and thus is statistically unlikely to be noticeable at this stage within a smaller subset of neuronal types. A different time point may address the possibility of delayed differentiation.

8\) The phenotype should be characterized and discussed with greater depth. Do the ratios between different neuronal types change? This can be assayed with double FISH. If the ratios have changed, how should we understand the activity of *tec-1* in different neuronal populations? Are there any neuronal types within the CNS or PNS that reduce in numbers or are not affected after RNAi? Neuronal types unaffected by *tec-1* may bring important insights and hypotheses. Readers would appreciate the authors\' insights to these questions. If all neuronal types increase in numbers within a constant brain size, it might suggest that the neurons must reduce their sizes as they experience a cellular overcrowding effect. Is this effect measurable (e.g., through nucleus-nucleus distance)? Are the changes in number density and cell size consistent? The authors have shown that glial cell number mildly decreases, which is very interesting, but is this change enough to compensate the increase of all neurons? How should we interpret this result -- is it explained by the hypothesis of a distinct cell population killing neurons, or might this have any basis in a potential differentiation pathway?

9\) The choice of timing for the irradiation experiment needs to be explained as well. This experiment shows that in the absence of new cell production, *tec-1*RNAi animals continue to expand numbers of *cto+* cells, whereas control RNAi animals show a decrease in *cto+* cells at day 12 relative to day 10. However, Figure 4B showed a statistically significant different in *cto+* cells between control and *tec-1* RNAi animals on day 10 (which was also detectable as significant on day 8). If differentiation is not a source of *cto+* differences between control and *tec-1*RNAi animals, one would expect the differences to be the same upon elimination of the contribution of new cells (at least at day 8). What explains the non-significant differences at day 8 and 10 in Figure 5B? Do the results argue that both differentiation and cell survival are affected?

10\) The authors report that Tec kinases are known to control inflammation and recovery following traumatic brain injury by regulating macrophages, which does not directly imply that Tec kinase homologs regulate neuronal cell numbers via controlling their survival. Therefore, the next statement ("We suggest that Tec kinases could regulate specific and perhaps conserved functions in adult neurogenesis process in control of neuron abundance") is not well-supported. There are no data presented that enable the proposal of a putative conserved function for *tec-1*. The authors\' finding that planarian regeneration involves overproduction of neural cells followed by cell death bears overall similarity to the mechanisms of vertebrate development where cell death plays a major role in shaping the nervous system. However, given the lack of demonstrated similarity of function of the ortholog of *tec-1* in neural development in vertebrates, the claims of *tec-1* being a promising new target for therapeutic interventions are premature.

11\) Finally, the finding of increased density of glial cells in *tec-1*RNAi is interesting, and the authors should discuss if this could be suggestive of *tec-1* being involved in a fate choice -- could glial cells and *cto+* cells be differentiating from a shared progenitor population?
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Author response

> Essential revisions:
>
> In order to consider this manuscript further, several major issues in terms of the phenotype and interpretation need to be addressed. These are:
>
> 1\) The expression of tec-1 is unclear. While the cell atlas suggests it is broadly expressed and perhaps concentrated in the neuronal progenitors, where is it expressed during regeneration? Does the expression pattern change throughout the regeneration time course? This information is essential, as it should inform the interpretation of phenotypes in terms of whether tec-1 functions autonomously or non-autonomously. Is tec-1 co-expressed with any of the neuronal or progenitor types looked at in the paper? Or is it co-expressed with macrophage/phagocytic markers? If FISH is challenging in whole-mount, it is worth trying in sections and dissociated cells.

We appreciate this suggestion and now show FISH images of *tec-1* expression in whole animals. Indeed, in confirmation of the scRNAseq data, we find *tec-1* FISH signal to be broadly distributed, with co-expression analysis confirming expression in several different neurons, *piwi-1+* cells, and glia (Figure 4---figure supplement 3). We also examine overall *tec-1* expression during regeneration (Figure 4---figure supplement 1) and find it is also broadly expressed during regeneration with no obvious injury-induced expression behavior. The broadness of expression implies that we cannot at present rule out the possibility of *tec-1* acting within either neural progenitors, differentiated neurons, or some other cell type to exert its function on neuron numbers, and we clarify this interpretation in the text (Discussion paragraph three).

> 2\) Control and tec-1 RNAi animals were compared in terms of differences in differentiation 8 days upon amputation. A BrdU pulse was delivered on day 2 to capture to trace the progeny of cells that were in S phase during the pulse (the duration of this pulse is not specified but should be). The result of this experiment is clear -- no significant difference in the number of BrdU^+^ cells in the ppl+ cell population (which was affected in tec-1 RNAi much like cto+ cells). While this work supports the conclusion that tec-1 RNAi does not affect differentiation of cells in S-phase on day 2, it does not rule out differences in differentiation that may occur prior to or later than this time point. The numbers of progenitors marked by coe, pax6, and pitx were only compared 8 days post amputation, which also does not eliminate the idea that differentiation might be affected by tec-1 at other time points. Is it known that commitment to differentiated fates only begins on day 2 and that differentiation commitment later than day 2 does not contribute to fully differentiated cell types in a significant way? Or that differentiation rates are constant over time as the worms regenerate? Could the original observation that tec-1 RNAi animals show larger numbers of cto+ cells later in regeneration be explained by really early (before day 2) differences?

We have repeated the BrdU experiment by adding multiple time points for BrdU soaking and animal fixation during regeneration in Figure 4B (all combinations of soaking at day 0, 2, 4 and fixing at regeneration day 6, 8, 10, 12). These experiments did not find any differences between numbers of BrdU+*ppl-1*+ cells across all timepoints of regeneration or soaking tested. To support these conclusions, we also conducted an expanded neural progenitor counting experiments across a large range of timepoints in regeneration (Figure 4C), and confirm that we could not detect any excess rates of differentiation in *tec-1*RNAi animals.

> 3\) Does tec-1 function similarly during regeneration and homeostasis? In Figure 4A, the difference between control and tec-1 RNAi increases over time, suggesting more neurons should be removed as regeneration progresses. But the system has to reach a steady state eventually, but there is no data showing this. How and when might the steady state be reached in this case? Is it possible that tec-1 RNAi animals just have a delayed peak of neuronal deaths? In this case, the steady states may be similar between control and RNAi. The comparison of neurons between control and RNAi conditions should be performed after the system reaches a steady state.

We now include a longer time course showing that the steady state is reached by day 14 and the phenotype persisted through at least 28 days of regeneration (Figure 4---figure supplement 2). Based on observing similar overall phenotypes in regeneration or homeostasis assays, we suggest *tec-1* has a common role in negatively regulating neurogenesis, with each particular assay influencing the kinetics of response.

> 4\) In the tec-1 RNAi the numbers of many neuronal cell types go up, in particular in the brain region, but the size of the brain doesn\'t change. It is clearly visible in the staining that the density of the evaluated neuronal cell types is increased. But how does this work? Is the general cell density in the brain region higher? Are the cells smaller? Or are there compensatory losses of other cell types in the region? Could the detected loss in glial cells be sufficient to compensate?

To consider this, we performed 3D segmentation of *cintillo* cells from confocal stacks and made measurements of cell volume and the nearest-neighbor distances for each cell. This approach found that in *tec-1 RNAi, cintillo* cells were more numerous and slightly smaller, and also that they are more densely packed with respect to each other (Figure 2---figure supplement 2). We suggest that increased density along with reduced size accounts for how more neurons physically occupy apparently similar brain volumes in *tec-1*RNAi.

> 5\) The authors state that there are no changes in polarity or global patterning genes, but Figure 2B shows a clear increase in the number of notum-expressing cells, and Figure 3B clearly shows disorganized photoreceptors. This suggests that there are definitely some -- possibly subtle -- changes in anterior organization. It would be very interesting to understand whether the change in notum levels could induce this change in responsiveness to apoptotic signals. In addition, there have been some indications that apoptosis is not constant along the A-P axis (e.g. Peiris et al., 2016), and it would be worth taking into consideration whether this might explain some of the observed phenotype.

To address this, we used FISH to more carefully detect and pinpoint the excess *notum+* cells. These excess cells were found to be within a previously described set of *notum+chat+* cells of the brain (Figure 2---figure supplement 1), which we interpret to be consistent with the supported role of *tec-1* to limit numbers of multiple types of neurons. We suggest based on our analysis that *tec-1* likely acts in an independent process from other known head patterning genes (such as *notum, wnt11-6/wntA, ndk*, etc), because *tec-1* inhibition primarily influences neuron cell density versus head regionalization.

We appreciate the suggestion to consider whether *tec-1* could be part of the previously characterized A-P axis apoptotic pathway. To test this, we searched the recently published scRNAseq planarian cell atlas to find a neuron subtype that was broadly distributed but disperse enough that total animal cell quantifications could be carried out confidently. Of the tested neuron subtypes, we found one marker (*dd2223*, labeling nonciliated neuron cluster\#32 identified by Fincher et al., 2018) that was strongly sensitive to *tec-1* inhibition. In *tec-1*RNAi animals, we found an equivalent increase in *dd2223+* neuron cells in anterior versus posterior body regions (Figure 3---figure supplement 2). Therefore, our findings suggest *tec-1* can exert its influence independent of A-P axis position, so we suggest it is likely part of a distinct pathway from factors specifically influencing anterior versus posterior cell survival.

> 6\) Is there an anterior bias in the detected neuronal cell increase? Most of the neuronal cell types are evaluated in the anterior region. Only the bottom panel in Figure 3A shows a change in a more posterior region. Are the effects mostly detected in the anterior, or are neuronal cell increases in the posterior just as strong?

Similar to above, to test this, we searched the recently published scRNAseq planarian cell atlas to find a neuron subtype that was broadly distributed but disperse enough that total animal cell quantifications could be carried out confidently. Of the tested neuron subtypes, we found one marker (*dd2223*, labeling nonciliated neuron cluster\#32 identified by Fincher et al., 2018) that was strongly sensitive to *tec-1* inhibition. In *tec-1*RNAi animals, we found an equivalent increase in *dd2223+* neuron cells in anterior versus posterior body regions (Figure 3---figure supplement 2). Therefore, *tec-1* can exert its influence independent of AP axis position.

> 7\) Is it possible that tec-1 RNAi causes a prolonged differentiation? There is a caveat in terms of Figure 4C showing tec-1\'s disinvolvement with rate of neuronal differentiation. The regenerating tail fragments were examined at day 8 post-amputation, at which point Figure 4A suggests has only a slight increase in neuronal abundance and thus is statistically unlikely to be noticeable at this stage within a smaller subset of neuronal types. A different time point may address the possibility of delayed differentiation.

We tested the possibility of delayed differentiation through an extended set of measurements over time (2, 4, 8, 12 days head regeneration) and for 3 different neural progenitors during regeneration. In all three cases (*coe, pax6A, pitx*), we found that both control and *tec-1*RNAi animals undergo a similar reduction of progenitor numbers during regeneration. There was no significant difference in progenitor numbers between control and *tec-1*RNAi animals at all timepoints throughout regeneration (day 2-day 12) (Figure 4C). Therefore, we do not find evidence for *tec-1* inhibition prolongs a period of higher differentiation in regeneration.

> 8\) The phenotype should be characterized and discussed with greater depth. Do the ratios between different neuronal types change? This can be assayed with double FISH. If the ratios have changed, how should we understand the activity of tec-1 in different neuronal populations? Are there any neuronal types within the CNS or PNS that reduce in numbers or are not affected after RNAi? Neuronal types unaffected by tec-1 may bring important insights and hypotheses. Readers would appreciate the authors\' insights to these questions. If all neuronal types increase in numbers within a constant brain size, it might suggest that the neurons must reduce their sizes as they experience a cellular overcrowding effect. Is this effect measurable (e.g., through nucleus-nucleus distance)? Are the changes in number density and cell size consistent? The authors have shown that glial cell number mildly decreases, which is very interesting, but is this change enough to compensate the increase of all neurons? How should we interpret this result -- is it explained by the hypothesis of a distinct cell population killing neurons, or might this have any basis in a potential differentiation pathway?

Using double-FISH, we now include experiments to examine the ratio of *cto*+ neurons to other neuron types in Figure 3---figure supplement 3. These revealed no alteration of cto:gad or cto:ppl1 cell ratios after *tec-1*RNAi, suggesting *tec-1*concordantly affects the abundance of multiple neuron types.

To expand the analysis of the phenotype we examined five additional neuron subtypes identified in the recent scRNAseq cell atlas for planarians. Though planarians may have \~50 different types of neurons, the effect size of the *tec-1*RNAi phenotype led us to focus on cell types for which total body enumeration could be performed at a high degree of precision. Of the 5 genes we found to meet this criteria, 4 underwent tec-1 dependent increases (Figure 3A and Figure 3---figure supplement 2): *dd2223, dd3733, spp-4, dd17258*) and the other did not change in abundance after *tec-1*RNAi (*dd2723*). Altogether, our analysis now finds 10 of 13 neuron types increased after *tec-1*RNAi, and 3 of 13 did not change (note we found none that decreased in number). Those unaffected by *tec-1* inhibition did not have any known discernable commonality in terms of location or distribution (opsin+ photoreceptor neurons, *ppl1+* pharyngeal neurons, *dd2723+* CNS cells of the brain, ventral nerve cords, and pharynx). These findings, in combination with the broad expression of *tec-1*, prevented us from identifying a best hypothesis at this time for why some neurons are affected by *tec-1* and some are not.

We appreciate the suggestion to determine how extra neurons in *tec-1(RNAi)* animals physically pack in space, given for example that overall brain size is not affected. To address this, we performed 3D segmentation on *cintillo*-stained animals and computed volume and nearest neighbor distances between the cells (Figure 2---figure supplement 1). This approach found that *tec-1* inhibition indeed results in overcrowding of *cto+* neurons, leading to higher neuron densities and smaller volumes of *cto+* cells. Perhaps as extra neurons grow, some process constrains overall tissue volume, leading to these cells attaining reduced sizes. Based on the separation of regions occupied by glia and the affected neuron cell types, we believe the crowding effect to be a separate phenomenon than loss of glial abundance or size. In combination with additional experiments showing lack of support for increased differentiation of neurons (BrdU staining, progenitor counting), our analysis suggests *tec-1* is unlikely to function in a switch to control glial-vs-neuron differentiation.

> 9\) The choice of timing for the irradiation experiment needs to be explained as well. This experiment shows that in the absence of new cell production, tec-1 RNAi animals continue to expand numbers of cto+ cells, whereas control RNAi animals show a decrease in cto+ cells at day 12 relative to day 10. However, Figure 4B showed a statistically significant different in cto+ cells between control and tec-1 RNAi animals on day 10 (which was also detectable as significant on day 8). If differentiation is not a source of cto+ differences between control and tec-1 RNAi animals, one would expect the differences to be the same upon elimination of the contribution of new cells (at least at day 8). What explains the non-significant differences at day 8 and 10 in Figure 5B? Do the results argue that both differentiation and cell survival are affected?

We chose this timing in order to attempt to generate a pulse of new neurons whose behavior could be assessed over time. In contexts of head regeneration, the exact timing of the onset of the *tec-1* excess *cto+* cell phenotype was somewhat variable across experiments, dependent on feeding schedule and fragment type (note that Figure 4A analyzed tail fragments while Figure 5B analyzed trunk fragments). For the irradiation experiment, we chose trunk fragments because they can survive for longer as compared to irradiated tail fragments. In those fragments, we never observed the excess *cto+* phenotype at d8 but only observed it emerge at later times -- by day 12 in head regeneration, the phenotype was always observed. We repeated the experiment in Figure 5B three times and observed in each case the *tec-1*RNAi phenotype in irradiated animals by day 12. Our interpretation of the BrdU labeling and progenitor counting experiments is that we were unable to observe any effect of *tec-1* inhibition on differentiation.

> 10\) The authors report that Tec kinases are known to control inflammation and recovery following traumatic brain injury by regulating macrophages, which does not directly imply that Tec kinase homologs regulate neuronal cell numbers via controlling their survival. Therefore, the next statement ("We suggest that Tec kinases could regulate specific and perhaps conserved functions in adult neurogenesis process in control of neuron abundance") is not well-supported. There are no data presented that enable the proposal of a putative conserved function for tec-1. The authors\' finding that planarian regeneration involves overproduction of neural cells followed by cell death bears overall similarity to the mechanisms of vertebrate development where cell death plays a major role in shaping the nervous system. However, given the lack of demonstrated similarity of function of the ortholog of tec-1 in neural development in vertebrates, the claims of tec-1 being a promising new target for therapeutic interventions are premature.

We appreciate this suggestion to the presentation. We clarified our reference to the study noted above, that it found an increase in brain cell survival (ie, reduced staining of cell death markers) in an ischemic brain injury model after pharmacological inhibition of the Tec-family kinase BTK in mammals (Discussion paragraph five).

We also modified the text suggesting that our study necessarily implies the existence of a conserved activity of *tec-1* to suppress neurogenesis. Given that some components of neurogenesis are broadly conserved, we think it is worthwhile to raise the idea that future studies could address this possibility. In addition, we now tone down statements of the concept for a potential use for *tec-1* inhibition to enhance neurogenesis (given additional study). We hope our revised text makes clear that we do not present evidence for a conserved function in this study:

Abstract: "In vertebrates, the Tec kinase family has been studied extensively for roles in immune function, and our results identify a novel role for *tec-1* as negative regulator of planarian adult neurogenesis."

Discussion paragraph five: "If the ability of Tec Kinases to limit neuron production ultimately proves to be conserved, they would be potential targets for enhancing neural repair in other species."

Discussion paragraph four: "It is possible that Tec kinases could regulate conserved functions in adult neurogenesis processes in control of neuron abundance."

> 11\) Finally, the finding of increased density of glial cells in tec-1 RNAi is interesting, and the authors should discuss if this could be suggestive of tec-1 being involved in a fate choice -- could glial cells and cto+ cells be differentiating from a shared progenitor population?

We appreciate this suggestion, as it was indeed our initial hypothesis leading us to examine the glia in *tec-1*RNAi. We have added text discussing the hypothesis of a *tec-1* functioning in a neuron-glial differentiation switch, but also how our experiments would suggest against this model because of finding no evidence for *tec-1* inhibition to increase rates of neuron differentiation (subsection "*tec-1* suppresses neuronal cell number by regulating cell survival").
